Benzinga | Aug 12, 2020 04:12PM EDT

ImmuCell Q2 EPS $(0.11) Misses $(0.10) Estimate, Sales $2.97M Up From $2.71M YoY

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 22.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported $2.97 million in sales this quarter. This is a 9.45 percent increase over sales of $2.71 million the same period last year.